These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 16887362
1. Inverse correlation between serum free IGF-I and IGFBP-3 levels and blood pressure in patients affected with type 1 diabetes. Capoluongo E, Pitocco D, Lulli P, Minucci A, Santonocito C, Manto A, Di Stasio E, Zaccardi F, Zuppi C, Ghirlanda G, Ameglio F. Cytokine; 2006 Jun; 34(5-6):303-11. PubMed ID: 16887362 [Abstract] [Full Text] [Related]
2. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications. Capoluongo E, Pitocco D, Santonocito C, Concolino P, Santini SA, Manto A, Lulli P, Ghirlanda G, Zuppi C, Ameglio F. Eur Cytokine Netw; 2006 Sep; 17(3):167-74. PubMed ID: 17194636 [Abstract] [Full Text] [Related]
4. "Inverse correlation between serum free IGF-1 and IGFBP-3 levels and blood pressure in patients affected with type 1 diabetes" by Capoluongo et al. Boucher BJ. Cytokine; 2007 Mar; 37(3):181-2; author reply 183-4. PubMed ID: 17379532 [No Abstract] [Full Text] [Related]
5. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF). Brausewetter F, Jehle PM, Jung MF, Boehm BO, Brueckel J, Hombach V, Osterhues HH. Horm Metab Res; 2001 Dec; 33(12):713-20. PubMed ID: 11753756 [Abstract] [Full Text] [Related]
6. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes. Hedman CA, Frystyk J, Fridell K, Jönsson A, Flyvbjerg A, Lindström T, Arnqvist HJ. Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412 [Abstract] [Full Text] [Related]
7. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus. Akturk M, Arslan M, Altinova A, Ozdemir A, Ersoy R, Yetkin I, Ayvali E, Gonen S, Toruner F. Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141 [Abstract] [Full Text] [Related]
8. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults. Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB. Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406 [Abstract] [Full Text] [Related]
9. [Changes in IGF-I levels and its binding proteins in diabetes mellitus and obesity]. Krsek M, Skrha J, Sucharda P, Justová V, Lacinová Z. Cas Lek Cesk; 2003 Dec; 142(4):216-9. PubMed ID: 12841123 [Abstract] [Full Text] [Related]
10. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum. Berrigan D, Potischman N, Dodd KW, Nicar M, McQuillan G, Lavigne JA, Barrett JC, Ballard-Barbash R. Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631 [Abstract] [Full Text] [Related]
11. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions. Dinleyici EC, Kilic Z, Buyukkaragoz B, Ucar B, Alatas O, Aydogdu SD, Dogruel N. Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262 [Abstract] [Full Text] [Related]
12. [IGFBP-1 and its protective role in the pathogenesis of microangiopathy in type 1 diabetes mellitus]. Krsek M, Prázný M, Skrha J, Justová V, Lacinová Z. Cas Lek Cesk; 2001 Apr 26; 140(8):234-7. PubMed ID: 11392040 [Abstract] [Full Text] [Related]
13. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy]. Peczyńska J, Urban M, Urban B, Głowińska B, Florys B. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004 Apr 26; 10(1):41-8. PubMed ID: 15355738 [Abstract] [Full Text] [Related]
14. The insulin-like growth factor system and Type 1 diabetic retinopathy during pregnancy. Loukovaara S, Immonen IJ, Koistinen R, Rutanen EM, Hiilesmaa V, Loukovaara M, Kaaja RJ. J Diabetes Complications; 2005 Apr 26; 19(5):297-304. PubMed ID: 16112506 [Abstract] [Full Text] [Related]
15. Cord blood IGF-1 and IGFBP-3 levels in asphyxiated term newborns. Dinleyici EC, Tekin N, Colak O, Aksit MA. Neuro Endocrinol Lett; 2006 Dec 26; 27(6):745-7. PubMed ID: 17187018 [Abstract] [Full Text] [Related]
16. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth. Yildiz B, Kural N, Colak O, Ak I, Akcar N. Clin Physiol Funct Imaging; 2008 Mar 26; 28(2):107-12. PubMed ID: 18093232 [Abstract] [Full Text] [Related]
17. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease. Akanji AO, Suresh CG, Al-Radwan R, Fatania HR. Scand J Clin Lab Invest; 2007 Mar 26; 67(5):553-9. PubMed ID: 17763192 [Abstract] [Full Text] [Related]
18. Serum levels of IGF-I and IGFBP-III and their relation with carcinoembryonic antigen and carbohydrate antigen 19-9 in cases of esophageal cancer. Yilmaz O, Eroglu A, Dag E, Karaoglanoglu N, Yilmaz A. Int J Clin Pract; 2006 Dec 26; 60(12):1604-8. PubMed ID: 16704680 [Abstract] [Full Text] [Related]
19. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer. Han JY, Choi BG, Choi JY, Lee SY, Ju SY. Lung Cancer; 2006 Nov 26; 54(2):227-34. PubMed ID: 16935391 [Abstract] [Full Text] [Related]
20. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants. Akcakus M, Koklu E, Kurtoglu S, Kula M, Koklu SS. Am J Perinatol; 2006 Nov 26; 23(8):473-80. PubMed ID: 17094045 [Abstract] [Full Text] [Related] Page: [Next] [New Search]